1
|
Zuccolo M, Arrighetti N, Perego P, Colombo D. Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds. Curr Med Chem 2021; 29:2566-2601. [PMID: 34365939 DOI: 10.2174/0929867328666210806110857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 06/09/2021] [Accepted: 06/15/2021] [Indexed: 11/22/2022]
Abstract
Platinum (Pt) drugs, including cisplatin, are widely used for the treatment of solid tumors. Despite the clinical success, side effects and occurrence of resistance represent major limitations to the use of clinically available Pt drugs. To overcome these problems, a variety of derivatives have been designed and synthetized. Here, we summarize the recent progress in the development of Pt(II) and Pt(IV) complexes with bioactive ligands. The development of Pt(II) and Pt(IV) complexes with targeting molecules, clinically available agents, and other bioactive molecules is an active field of research. Even if none of the reported Pt derivatives has been yet approved for clinical use, many of these compounds exhibit promising anticancer activities with an improved pharmacological profile. Thus, planning hybrid compounds can be considered as a promising approach to improve the available Pt-based anticancer agents and to obtain new molecular tools to deepen the knowledge of cancer progression and drug resistance mechanisms.
Collapse
Affiliation(s)
- Marco Zuccolo
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan. Italy
| | - Noemi Arrighetti
- Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. Italy
| | - Paola Perego
- Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. Italy
| | - Diego Colombo
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan. Italy
| |
Collapse
|
2
|
Functionalization of new anticancer Pt(II) complex with transferrin receptor binding peptide. Inorganica Chim Acta 2020. [DOI: 10.1016/j.ica.2020.119811] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
3
|
Kumbhakonam S, Vellaisamy K, Saroj S, Venkatesan N, D. K, Kannoth Manheri M. Serine- and threonine-derived diamine equivalents for site-specific incorporation of platinum centers in peptides, and the anticancer potential of these conjugates. NEW J CHEM 2018. [DOI: 10.1039/c7nj03999a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A modular strategy that gives access to a library of peptide–Pt conjugates and their anticancer potential is presented.
Collapse
Affiliation(s)
| | | | - Soumya Saroj
- Department of Chemistry
- Indian Institute of Technology Madras
- Chennai
- India
| | - Nalini Venkatesan
- Department of Biotechnology
- Indian Institute of Technology Madras
- Chennai
- India
| | - Karunagaran D.
- Department of Biotechnology
- Indian Institute of Technology Madras
- Chennai
- India
| | | |
Collapse
|
4
|
Johnstone TC, Suntharalingam K, Lippard SJ. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev 2016; 116:3436-86. [PMID: 26865551 PMCID: PMC4792284 DOI: 10.1021/acs.chemrev.5b00597] [Citation(s) in RCA: 1654] [Impact Index Per Article: 206.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer, but new platinum agents have been very slow to enter the clinic. Recently, however, there has been a surge of activity, based on a great deal of mechanistic information, aimed at developing nonclassical platinum complexes that operate via mechanisms of action distinct from those of the approved drugs. The use of nanodelivery devices has also grown, and many different strategies have been explored to incorporate platinum warheads into nanomedicine constructs. In this Review, we discuss these efforts to create the next generation of platinum anticancer drugs. The introduction provides the reader with a brief overview of the use, development, and mechanism of action of the approved platinum drugs to provide the context in which more recent research has flourished. We then describe approaches that explore nonclassical platinum(II) complexes with trans geometry or with a monofunctional coordination mode, polynuclear platinum(II) compounds, platinum(IV) prodrugs, dual-threat agents, and photoactivatable platinum(IV) complexes. Nanoparticles designed to deliver platinum(IV) complexes will also be discussed, including carbon nanotubes, carbon nanoparticles, gold nanoparticles, quantum dots, upconversion nanoparticles, and polymeric micelles. Additional nanoformulations, including supramolecular self-assembled structures, proteins, peptides, metal-organic frameworks, and coordination polymers, will then be described. Finally, the significant clinical progress made by nanoparticle formulations of platinum(II) agents will be reviewed. We anticipate that such a synthesis of disparate research efforts will not only help to generate new drug development ideas and strategies, but also will reflect our optimism that the next generation of approved platinum cancer drugs is about to arrive.
Collapse
Affiliation(s)
- Timothy C Johnstone
- Department of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States
| | | | - Stephen J Lippard
- Department of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States
| |
Collapse
|
5
|
Sista P, Ghosh K, Martinez JS, Rocha RC. Metallo-Biopolymers: Conjugation Strategies and Applications. POLYM REV 2014. [DOI: 10.1080/15583724.2014.913063] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
6
|
Chow MJ, Licona C, Yuan Qiang Wong D, Pastorin G, Gaiddon C, Ang WH. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly. J Med Chem 2014; 57:6043-59. [PMID: 25023617 DOI: 10.1021/jm500455p] [Citation(s) in RCA: 109] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
The structural diversity of metal scaffolds makes them a viable alternative to traditional organic scaffolds for drug design. Combinatorial chemistry and multicomponent reactions, coupled with high-throughput screening, are useful techniques in drug discovery, but they are rarely used in metal-based drug design. We report the optimization and validation of a new combinatorial, metal-based, three-component assembly reaction for the synthesis of a library of 442 Ru-arene Schiff-base (RAS) complexes. These RAS complexes were synthesized in a one-pot, on-a-plate format using commercially available starting materials under aqueous conditions. The library was screened for their anticancer activity, and several cytotoxic lead compounds were identified. In particular, [(η6-1,3,5-triisopropylbenzene)RuCl(4-methoxy-N-(2-quinolinylmethylene)aniline)]Cl (4) displayed low micromolar IC50 values in ovarian cancers (A2780, A2780cisR), breast cancer (MCF7), and colorectal cancer (HCT116, SW480). The absence of p53 activation or changes in IC50 value between p53+/+ and p53-/- cells suggests that 4 and possibly the other lead compounds may act independently of the p53 tumor suppressor gene frequently mutated in cancer.
Collapse
Affiliation(s)
- Mun Juinn Chow
- Department of Chemistry, National University of Singapore , 3 Science Drive 3, 117543 Singapore
| | | | | | | | | | | |
Collapse
|
7
|
D'Errico S, Oliviero G, Borbone N, Piccialli V, Pinto B, De Falco F, Maiuri MC, Carnuccio R, Costantino V, Nici F, Piccialli G. Synthesis and pharmacological evaluation of modified adenosines joined to mono-functional platinum moieties. Molecules 2014; 19:9339-53. [PMID: 24995920 PMCID: PMC6271865 DOI: 10.3390/molecules19079339] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2014] [Revised: 06/23/2014] [Accepted: 06/25/2014] [Indexed: 12/23/2022] Open
Abstract
The synthesis of four novel platinum complexes, bearing N6-(6-amino-hexyl)adenosine or a 1,6-di(adenosin-N6-yl)-hexane respectively, as ligands of mono-functional cisplatin or monochloro(ethylendiamine)platinum(II), is reported. The chemistry exploits the high affinity of the charged platinum centres towards the N7 position of the adenosine base system and a primary amine of an alkyl chain installed on the C6 position of the purine. The cytotoxic behaviour of the synthesized complexes has been studied in A549 adenocarcinomic human alveolar basal epithelial and MCF7 human breast adenocarcinomic cancer cell lines, in order to investigate their effects on cell viability and proliferation.
Collapse
Affiliation(s)
- Stefano D'Errico
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Giorgia Oliviero
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Nicola Borbone
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Vincenzo Piccialli
- Dipartimento di Scienze Chimiche, Università degli Studi di Napoli "Federico II", via Cintia, 21, 80126 Napoli, Italy.
| | - Brunella Pinto
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Francesca De Falco
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Maria Chiara Maiuri
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Rosa Carnuccio
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Valeria Costantino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Fabrizia Nici
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| | - Gennaro Piccialli
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", via D. Montesano, 49, 80131 Napoli, Italy.
| |
Collapse
|
8
|
Accardo A, Mangiapia G, Paduano L, Morelli G, Tesauro D. Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery. J Pept Sci 2013; 19:190-7. [DOI: 10.1002/psc.2481] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2012] [Revised: 12/14/2012] [Accepted: 12/17/2012] [Indexed: 01/21/2023]
Affiliation(s)
- Antonella Accardo
- CIRPeB, Department of Biological Sciences and IBB CNR; University of Naples ‘Federico II’ Via Mezzocannone; 16-80134 Napoli Italy
| | - Gaetano Mangiapia
- Department of Chemical Sciences; University of Naples ‘Federico II’; Via Cynthia 80126 Napoli Italy
| | - Luigi Paduano
- Department of Chemical Sciences; University of Naples ‘Federico II’; Via Cynthia 80126 Napoli Italy
| | - Giancarlo Morelli
- CIRPeB, Department of Biological Sciences and IBB CNR; University of Naples ‘Federico II’ Via Mezzocannone; 16-80134 Napoli Italy
| | - Diego Tesauro
- CIRPeB, Department of Biological Sciences and IBB CNR; University of Naples ‘Federico II’ Via Mezzocannone; 16-80134 Napoli Italy
| |
Collapse
|
9
|
Dodd DW, Damjanovski S, Hudson RE. Peptide nucleic acid Pt(II) conjugates: a preliminary study of antisense effects in Xenopus laevis. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2011; 30:257-63. [PMID: 21623539 DOI: 10.1080/15257770.2011.580290] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The avid hybridization of peptide nucleic acid (PNA) to DNA and RNA, coupled with the analogue's stability toward enzymatic degradation, has led to its investigation as an antigene/antisense agent. PNA targeted toward the 5'-UTR of an mRNA transcript can effect efficient silencing; however, if targeted to an area within the coding region, the PNA can be displaced by the moving ribosome and be an ineffective antisense agent. Platinum-appended and standard PNAs antisense to an area within the open-reading frame of the gene noggin, were injected into Xenopus laevis embryos. Phenotypic responses were observed and the preliminary results are reported herein.
Collapse
Affiliation(s)
- David W Dodd
- Department of Chemistry, The University of Western Ontario, London, Ontario, Canada
| | | | | |
Collapse
|
10
|
D’Errico S, Oliviero G, Piccialli V, Amato J, Borbone N, D’Atri V, D’Alessio F, Noto RD, Ruffo F, Salvatore F, Piccialli G. Solid-phase synthesis and pharmacological evaluation of novel nucleoside-tethered dinuclear platinum(II) complexes. Bioorg Med Chem Lett 2011; 21:5835-8. [DOI: 10.1016/j.bmcl.2011.07.104] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2011] [Revised: 07/26/2011] [Accepted: 07/27/2011] [Indexed: 10/17/2022]
|
11
|
Lamshöft M, Ivanova B. Protonation and coordination ability of small peptides – theoretical and experimental approaches for elucidation. J COORD CHEM 2011. [DOI: 10.1080/00958972.2011.598926] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Marc Lamshöft
- a Institute of Environmental Research of the Faculty of Chemistry, Dortmund University of Technology , Otto-Hahn-Str. 6, D-44227 Dortmund, Germany
| | - Bojidarka Ivanova
- a Institute of Environmental Research of the Faculty of Chemistry, Dortmund University of Technology , Otto-Hahn-Str. 6, D-44227 Dortmund, Germany
| |
Collapse
|
12
|
Heinze K, Beckmann M, Hempel K. Solid-Phase Synthesis of Transition-Metal Complexes. Chemistry 2008; 14:9468-80. [DOI: 10.1002/chem.200800697] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
13
|
Dirscherl G, König B. The Use of Solid‐Phase Synthesis Techniques for the Preparation of Peptide–Metal Complex Conjugates. European J Org Chem 2008. [DOI: 10.1002/ejoc.200700787] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Georg Dirscherl
- Institut für Organische Chemie, Universität Regensburg, 9340 Regensburg, Germany, Fax: +49‐941‐943‐1717
| | - Burkhard König
- Institut für Organische Chemie, Universität Regensburg, 9340 Regensburg, Germany, Fax: +49‐941‐943‐1717
| |
Collapse
|
14
|
Kirin SI, Yennawar HP, Williams ME. Synthesis and Characterization of CuII Complexes with Amino Acid Substituted Di(2-pyridyl)amine Ligands. Eur J Inorg Chem 2007. [DOI: 10.1002/ejic.200700273] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|